Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2866860

CCCCCCCCN(C)CCCCCCCC.Cl

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 known ✓ O95136 1/20 0.58
S1PR1 known ✓ P21453 1/20 0.58
S1PR3 known ✓ Q99500 1/20 0.58
S1PR5 known ✓ Q9H228 1/20 0.58
CHRM2 known ✓ P08172 1/20 0.52
AGTR1 known ✓ P30556 1/20 0.47
OPRM1 known ✓ P35372 1/20 0.47
PDE3A known ✓ Q14432 1/20 0.47
DNM1 Q05193 3/20 0.68
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50
GGPS1 O95749 4/20 0.48
KDM4C Q9H3R0 3/20 0.47
KDM5A P29375 2/20 0.47
PHF8 Q9UPP1 1/20 0.47
FDPS P14324 1/20 0.47
KDM4A O75164 1/20 0.46
GBA1 P04062 1/20 0.44
KDM5C P41229 1/20 0.44
KDM5B Q9UGL1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8431132 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL8852002 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL9201098 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL2857646 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL2864369 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL566088 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL131619 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL5984871 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL21523220 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5
Hydrochloric Acid SCHEMBL128515 1.00 DNM1 (0.68) DNM1S1PR2S1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117701267-A Pressure-reducing and injection-increasing surfactant system for low-permeability oil field and preparation method thereof 新疆光亚油气新技术发展有限公司 2024-03-15 CN claimed
CN-116949122-A Method for extracting protein polypeptide from walnut meal 河北绿岭合田食品有限公司 2023-10-27 CN claimed
CN-112010773-A Dehydrating agent and preparation method thereof, and hydrocarbon water cutting agent and preparation method thereof 深圳市辛骏翔科技有限公司 2020-12-01 CN claimed
US-4877915-A Process for preparing polyalkyl tetrahydronaphthalenes UNION CAMP CORPORATION (US) 1989-10-31 US claimed
US-12215181-B2 Anionic group III complexes as weakly coordinating anions for olefin polymerization catalyst activators DOW GLOBAL TECHNOLOGIES LLC (US) 2025-02-04 US disclosed
CN-117701267-B Pressure-reducing and injection-increasing surfactant system for low-permeability oil field and preparation method thereof 新疆光亚油气新技术发展有限公司 2024-05-14 CN disclosed
CN-117701267-A Pressure-reducing and injection-increasing surfactant system for low-permeability oil field and preparation method thereof 新疆光亚油气新技术发展有限公司 2024-03-15 CN disclosed
CN-116949122-A Method for extracting protein polypeptide from walnut meal 河北绿岭合田食品有限公司 2023-10-27 CN disclosed
CN-113631585-B Group III anionic complexes of weakly coordinating anions as olefin polymerization catalyst activators 陶氏环球技术有限责任公司 2023-10-20 CN disclosed
EP-3947479-B1 ANIONIC GROUP III COMPLEXES AS WEAKLY COORDINATING ANIONS FOR OLEFIN POLYMERIZATION CATALYST ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-12 EP disclosed
US-20220162352-A1 ANIONIC GROUP III COMPLEXES AS WEAKLY COORDINATING ANIONS FOR OLEFIN POLYMERIZATION CATALYST ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2022-05-26 US disclosed
EP-3947479-A1 ANIONIC GROUP III COMPLEXES AS WEAKLY COORDINATING ANIONS FOR OLEFIN POLYMERIZATION CATALYST ACTIVATORS Dow Global Technologies LLC (US) 2022-02-09 EP disclosed
EP-1650214-A2 Silicon compound CHISSO CORPORATION (JP) 2006-04-26 EP disclosed
US-20050250925-A1 Silicon compound JNC CORPORATION (JP) 2005-11-10 US disclosed
EP-1550664-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-07-06 EP disclosed
US-20050049381-A1 Silicon compounds YAMAHIRO MIKIO (JP) 2005-03-03 US disclosed
EP-0849292-B1 Olefin polymerisation catalysts and processes for producing olefin polymers TOSOH CORP (JP) 2002-08-21 EP disclosed
WO-2001046163-A2 3-NITRO-DIHYDRO-ISOXAZOLES AND OXAZINES AND THEIR USE AS MICROBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-06-28 WO disclosed
US-6110858-A AN OLEFIN POLYMERIZATION CATALYST CONSISTS OF A TRANSITION METAL COMPOUND, A MODIFIED CLAY COMPOUND CONTAINING CLAY MINERAL AND AN AMINE COMPOUND AND AN ORGANOALUMINUM COMPOUND TOSOH CORPORATION (JP) 2000-08-29 US disclosed
EP-0849292-A1 Olefin polymerisation catalysts and processes for producing olefin polymers TOSOH CORPORATION (JP) 1998-06-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12215181-B2 Anionic group III complexes as weakly coordinating anions for olefin polymerization catalyst activators YAP1, AP1G1, AP1M1 S1PR2 4223/4885S1PR1 4230/4885S1PR3 3506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.